[go: up one dir, main page]

KR100245390B1 - Low irritating cosmetic compositions containing alphahydroxy acids - Google Patents

Low irritating cosmetic compositions containing alphahydroxy acids Download PDF

Info

Publication number
KR100245390B1
KR100245390B1 KR1019970031102A KR19970031102A KR100245390B1 KR 100245390 B1 KR100245390 B1 KR 100245390B1 KR 1019970031102 A KR1019970031102 A KR 1019970031102A KR 19970031102 A KR19970031102 A KR 19970031102A KR 100245390 B1 KR100245390 B1 KR 100245390B1
Authority
KR
South Korea
Prior art keywords
weight
parts
acid
alpha hydroxy
water
Prior art date
Application number
KR1019970031102A
Other languages
Korean (ko)
Other versions
KR19990008898A (en
Inventor
김정아
경기열
윤명석
강세훈
Original Assignee
성재갑
주식회사엘지화학
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 성재갑, 주식회사엘지화학 filed Critical 성재갑
Priority to KR1019970031102A priority Critical patent/KR100245390B1/en
Publication of KR19990008898A publication Critical patent/KR19990008898A/en
Application granted granted Critical
Publication of KR100245390B1 publication Critical patent/KR100245390B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/064Water-in-oil emulsions, e.g. Water-in-silicone emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70Biological properties of the composition as a whole
    • A61K2800/72Hypo-allergenic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

본 발명은 알파히드록시산을 함유한 저자극성의 노화방지용 화장료로서 알파히드록시산을 휘발성 실리콘인 시클로메치콘이 유상중의 50.0 중량부 이상 구성하는 유중수형 유화물에 배합시키고, 세토스테아릴알코올-세라마이드-비이온 계면활성제-콜레스테롤 등으로 구성된 액정겔을 첨가할 때 피부 부작용을 현저히 줄여주며, 사용감 및 효과의 지속성이 우수한 화장품용 유화물을 제조할 수 있다.The present invention is a hypoallergenic anti-aging cosmetic containing alpha hydroxy acid, and alpha hydroxy acid is mixed with a water-in-oil type emulsion in which cyclomethicone, a volatile silicone, constitutes 50.0 parts by weight or more in an oil phase, and cetostearyl alcohol-ceramide. -When adding liquid crystalline gel composed of nonionic surfactant-cholesterol, it can significantly reduce skin side effects, and can produce cosmetic emulsion with excellent feeling of use and lasting effect.

Description

[발명의명칭][Name of invention]

알파히드록시산을 함유한 저자극성 화장료 조성물Hypoallergenic cosmetic composition containing alpha hydroxy acid

[발명의상세한설명]Detailed description of the invention

[발명의 목적][Purpose of invention]

본 발명은 알파히드록시산을 함유한 저자극성 화장료 조성물에 관한 것으로, 더욱 상세하게는 화장품에 보습 및 노화방지 성분으로 널리 사용되는 알파히드록시산 또는 그 염류를 유상에 있어서 실리콘 오일이 주성분인 유중수형 유화물에 배합하고, 여기에 세토스테아릴알코올-세라마이드-비이온 계면활성제-콜레스테롤 혼합계인 액정젤을 첨가함으로써, 알파히드록시산의 자극성을 줄이면서도 사용감촉이 양호하며 효과의 지속성이 탁월한 화장료 조성물에 관한 것이다.The present invention relates to a hypoallergenic cosmetic composition containing alpha hydroxy acid, and more particularly, to the alpha hydroxy acid or salt thereof widely used as a moisturizing and anti-aging ingredient in cosmetics, oil in which silicone oil is the main ingredient in the oil phase. A cosmetic composition blended with an aqueous emulsion and added with a liquid crystal gel, which is a cetostearyl alcohol-ceramide-nonionic surfactant-cholesterol mixture system, reduces the irritation of alpha hydroxy acids and has a good feeling of use and excellent durability of effects. It is about.

[발명이 속하는 기술분야 및 그 분야의 종래 기술의 간단한 설명]Brief description of the technical field to which the invention pertains and its prior art

화장품은 원래 인체를 청결 또는 보호, 미화하고 피부 또는 모발을 건강하게 유지하기 위하여 도찰, 살포, 기타 이와 유사한 방법으로 사용되는 것으로서 인체에 대한 작용이 경미한 것으로 정의되지만, 실제 사용하는 소비자들은 화장품의 사용으로 인해 피부의 노화방지, 미백효과 등 의약품적인 효과를 기대하고 있다. 따라서, 대부분의 화장품 제조회사들은 피부노화방지, 미백효과가 우수한 제품을 개발하고자 많은 노력을 기울이고 있다.Cosmetics were originally defined by painting, spraying, or other similar methods to clean or protect, beautify the human body, and keep skin or hair healthy, but are defined as mild to the human body. Due to this, anti-aging and whitening effect of the skin is expected to be a pharmaceutical effect. Therefore, most cosmetic manufacturers are making great efforts to develop products with excellent skin aging prevention and whitening effects.

현재까지 피부주름방지 및 제거 즉, 피부노화방지에 가장 탁월한 효능을 갖는 것으로는 비타민A 및 그 유도체와 알파히드록시산들이 대표적인 성분이라 할 수 있다. 그런데, 비타민A 및 그 유도체들은 여드름이나 주름 개선에 탁월한 효과가 인정되지만 제제 내에서의 안정성이 나쁘며, 많은 경우 피부 부작용을 일으켜 그 사용이 제한적이다. 알파히드록시산 역시 효과는 탁월한 것으로 인정되지만, 피부 부작용이 가장 큰 문제점으로 알려져 있다.Until now, vitamin A and its derivatives and alpha hydroxy acids may be the representative ingredients to have the most excellent efficacy in preventing and removing skin wrinkles. By the way, vitamin A and its derivatives are recognized to have an excellent effect on improving acne and wrinkles, but the stability in the formulation is poor, in many cases cause a skin side effect is limited in its use. Alpha hydroxy acids are also considered to be effective, but skin side effects are known to be the biggest problem.

[발명이 이루고자 하는 기술적 과제][Technical problem to be achieved]

본 발명자들은 피부노화방지 효과가 우수하면서도 피부 부작용이 적은 화장품을 개발하고자 연구한 결과, 알파히드록시산 또는 그 염류를 유상에 있어서 실리콘오일이 주성분인 유중수형 유화물에 배합하고, 여기에 세토스테아릴알코올-세라마이드-비이온 계면활성제-콜레스테롤의 혼합계인 액정겔을 첨가할 때, 알파히드록시산의 효과는 그대로 유지되면서 피부 부작용이 현저히 줄어든 것을 밝혀내고 본 발명을 완성하였다.The present inventors have studied to develop a cosmetic having excellent skin anti-aging effect and low skin side effects, and as a result, alpha hydroxy acid or its salt is blended into a water-in-oil emulsion whose silicone oil is a main component in the oil phase, and cetostearyl When the liquid crystal gel, which is a mixture of alcohol-ceramide-nonionic surfactant-cholesterol, was added, it was found that the side effects of the alpha hydroxy acid were significantly reduced while the side effects of the skin were significantly reduced.

[발명의 구성 및 작용][Configuration and Function of Invention]

본 발명은 알파히드록시산 또는 그의 염중 1종 또는 2종 이상을 0.5~20.0 중량부와 액정겔베이스를 0.5~10.0 중량부 배합한 것을 특징으로 하는 유중수 타입의 화장료 조성물에 관한 것이다.The present invention relates to a water-in-oil type cosmetic composition comprising 0.5 to 20.0 parts by weight of alpha hydroxy acid or one or more of its salts and 0.5 to 10.0 parts by weight of a liquid crystal gel base.

본 발명의 화장료 조성물에서 사용된 알파히드록시산이라 함은 첫 번째 탄소 즉, 알파 위치의 탄소에 수산기(히드록시기, -OH)를 갖는 유기산의 총칭으로 글리콜산, 젖산, 말산, 히드록시부틴산 등 및 이들을 pH 조절을 목적으로 알카리로 중화시킨 글리콜산나트륨, 글리콜산칼륨, 젖산나트륨, 젖산칼륨, 말산나트륨, 말산칼륨, 히드록시부틴산나트륨, 히드록시부틴산칼륨 등이 대표적인 물질들이다. 이들은 노폐된 각질을 쉽게 제거시켜 새로운 세포가 생성되도록 도와주어, 결국 피부를 건강하게 해주며 노화 및 주름을 방지하는 작용을 할뿐만 아니라 피부에 보습효과 및 미백효과를 상승시키는 작용이 있는 것으로 잘 알려져 있다(일본특허 공개 제94-279258 호, 세계 특허 제9427579호, 일본 특허 공개 제96-133946 호, 일본특허 공개 제94-234260 호).The alpha hydroxy acid used in the cosmetic composition of the present invention is a generic term for an organic acid having a hydroxyl group (hydroxy group, -OH) at the first carbon, that is, the carbon at the alpha position, such as glycolic acid, lactic acid, malic acid, hydroxybutyric acid, and the like. And sodium glycolate, potassium glycolate, sodium lactate, potassium lactate, sodium malate, potassium malate, sodium hydroxybutyrate, potassium hydroxybutyrate, and the like, which are neutralized with alkali for the purpose of pH adjustment. They are easily known to help remove old dead skin cells and create new cells, thus making skin healthy and preventing aging and wrinkles, as well as enhancing the skin's moisturizing and whitening effect. (Japanese Patent Publication No. 94-279258, World Patent No. 9447579, Japanese Patent Publication No. 96-133946, Japanese Patent Publication No. 94-234260).

그런데 전술한 바와 같이 알파히드록시산은 피부에 대한 효과는 우수하면서도 피부에 심각한 부작용 즉, 부종, 홍반, 따끔거림, 가려움, 화끈거림 등의 이상반응이 야기될 수 있다. 그러므로 지금까지 여러 발명자들에 의해 피부 부작용을 줄이고자 하는 시도가 이루어졌는데 미국특허 제5516793호에서는 비타민 C, 즉 아스코르빈산의 첨가에 의해 피부 자극을 줄이고자 하였으며, 유럽특허 제691126호에서는 무기성 분체를 함유시켜 이를 개선하고자 하였다. 그러나 알파히드록시산을 지방알콜과 결합시켜 에스테르 화합물로 만들 경우 피부 부작용은 어느 정도 줄일 수 있으나, 알파히드록시산 자체에 비하여 효과가 매우 떨어지며, 비타민 C 또는 무기성분체 등의 단순 첨가만으로는 알파히드록시산의 피부 부작용 문제를 근본적으로 해결하기 어렵다.However, as described above, the alpha hydroxy acid may have an excellent effect on the skin but may cause serious side effects such as edema, erythema, tingling, itching, burning, and the like. Therefore, attempts to reduce skin side effects have been made by various inventors so far. In US Pat. No. 55,16793, it has been tried to reduce skin irritation by the addition of vitamin C, that is, ascorbic acid. It was intended to improve this by containing powder. However, if side effects of skin are reduced to some extent when alpha hydroxy acid is combined with fatty alcohol to make ester compound, it is less effective than alpha hydroxy acid itself, and alpha hydride is added by simple addition of vitamin C or inorganic substance. It is difficult to fundamentally solve the skin side effects of oxyacids.

알파히드록시산의 피부 부작용은 높은 농도의 알파히드록시산이 피부에 일시적으로 접촉 및 침투하기 때문이라고 여겨진다. 따라서 본 발명에서는 피부에 직접 접촉되는 양을 조절함으로써 피부 부작용을 줄이고자 알파히드록시산을 유중수형 유화물에 배합하였으며, 여기에 세토스테아릴알코올-세라마이드-비이온 계면활성제-콜레스테롤로 이루어진 액정겔 베이스를 첨가시켜 유중수형 유화물과 액정겔 구조가 피부 보호막을 형성하여 알파히드록시산의 경피 흡수율을 조절함으로써 피부 부작용을 줄이는데 상승효과를 부여하였다.The skin side effects of alpha hydroxy acids are believed to be due to the temporary contact and penetration of high concentrations of alpha hydroxy acids into the skin. Therefore, in the present invention, in order to reduce skin side effects by controlling the amount of direct contact with the skin, alpha hydroxy acid was formulated into a water-in-oil emulsion, and a liquid crystal gel base composed of cetostearyl alcohol-ceramide-nonionic surfactant-cholesterol. Water-in-oil type emulsion and liquid crystal gel structure were added to form a protective film to control the transdermal absorption rate of alpha hydroxy acid.

본 발명에 있어서 유중수형 유화물이란 수중유형 유화제품에 비해 피부에 강한 오일막을 형성시켜 장시간 지속적으로 수분 및 피부활성 물질을 전달시킴으로써 피부보호 및 치료가 뛰어난 장점을 가지고 있다. 특히 외상이 휘발성 실리콘 오일로 구성된 유중수형 유화물은 일반적인 유중수형이 갖는 장점을 유지하면서 발림성이 나쁘고, 무겁고 끈적이는 사용감의 단점을 제거해준다. 본 발명에서 사용된 실리콘 오일이라 함은 환상의 디메틸 폴리실록산기를 3-6개 함유하는 시클로메티콘이다. 즉 본 발명의 화장료 조성물에서 사용된 유중수타입은 외상인 유상중에 시클로메치콘이 50.0 중량부 이상 함유된 것으로서, 시클로메티콘은 다음과 같은 기본구조식을 갖는 것이다.In the present invention, the water-in-oil type emulsion has an advantage of excellent skin protection and treatment by forming a strong oil film on the skin compared to the oil-in-water type emulsion product and delivering moisture and skin active substances continuously for a long time. In particular, the water-in-oil type emulsion composed of the volatile silicone oil of the external wound removes the disadvantages of poor application, heavy and sticky feeling while maintaining the advantages of the general water-in-oil type. The silicone oil used in the present invention is cyclomethicone containing 3-6 cyclic dimethyl polysiloxane groups. That is, the water-in-oil type used in the cosmetic composition of the present invention contains 50.0 parts by weight or more of cyclomethicone in the oil phase, which is a trauma, and cyclomethicone has the following basic structural formula.

Figure kpo00001
Figure kpo00001

또한, 액정(液晶, Liquid Cyrstal)이라 함은 고체와 액체의 중간적 상태로서 이는 대개 친수부분과 친유부분을 동시에 갖는 유기분자들이 친수부분은 친수부분끼리, 소수부분은 소수부분끼리 일정하게 배열하여 여러층을 이루고 있을 때(라멜라 구조) 생성되는 계를 말한다. 액정은 유화물 제조시 계면에서 생성되어 유화물을 안정화시키며, 생체 세포간지질의 구성형태와 유사한 라멜라 액정 구조를 형성함으로써 피부 보호막을 형성해 각종 수용성, 유용성 약효성분들의 효과적인 전달매체로서 응용되고 있다.Liquid Cyrstal is an intermediate state between a solid and a liquid. It is usually an organic molecule having both a hydrophilic part and a lipophilic part, and the hydrophilic part is hydrophilic part and the hydrophobic part is uniformly arranged. It refers to a system that is created when it forms several layers (lamellar structure). Liquid crystals are produced at the interface to stabilize emulsions, stabilize the emulsions, and form a lamellar liquid crystal structure similar to the constituents of biological intercellular lipids to form a skin protective film and are being applied as an effective delivery medium for various water-soluble and oil-soluble active ingredients.

본 발명의 화장료 조성물에서 사용되는 액정겔 베이스는 세라마이드 9.0~12.0 중량부, 콜레스테롤 2.0~4.0 중량부, 세토스테아릴알코올 1.0~3.0 중량부, 피이지-15 올레이트 3.0~7.0 중량부, 프로필렌글리콜 74.0~85.0 중량부로 구성된 것이다.Liquid crystal gel base used in the cosmetic composition of the present invention is 9.0 to 12.0 parts by weight of ceramide, 2.0 to 4.0 parts by weight of cholesterol, 1.0 to 3.0 parts by weight of cetostearyl alcohol, 3.0 to 7.0 parts by weight of Fiji-15 oleate, propylene glycol It is comprised of 74.0-85.0 parts by weight.

본 발명에 따른 화장료 조성물은 알파히드록시산 또는 그의 염을 0.5 내지 20.0 중량부와 세토스테아릴알코올 1.0~3.0 중량부, 세라마이드 9~12.0 중량부, 비이온 계면활성제로서 피이지-15 올레이트 3.0~7.0 중량부, 콜레스테롤 2.0~4.0 중량부 및 프로필렌글리콜 74.0~85.0 중량부로 구성된 지질액정겔 0.5 내지 10.0 중량부를 외상인 유상중에서 50 중량부 이상이 휘발성 실리콘인 시클로메치콘으로 구성된 유중수형 유화물에 배합하여 제조한다. 이와같이 제조된 화장료 조성물은 알파히드록시산에 의한 피부 부작용이 적다.The cosmetic composition according to the present invention comprises 0.5 to 20.0 parts by weight of alpha hydroxy acid or a salt thereof, 1.0 to 3.0 parts by weight of cetostearyl alcohol, 9 to 12.0 parts by weight of ceramide, and Fiji-15 oleate 3.0 as a nonionic surfactant. 0.5 to 10.0 parts by weight of a lipid liquid gel consisting of ˜7.0 parts by weight, 2.0 to 4.0 parts by weight of cholesterol and 74.0 to 85.0 parts by weight of propylene glycol, are incorporated in a water-in-oil type emulsion consisting of cyclomethicone which is 50 parts by weight or more in a traumatic oil phase. To prepare. The cosmetic composition thus prepared has less skin side effects due to alpha hydroxy acid.

여기서 알파히드록시산을 0.5 이하 사용하면 효과가 미미하며, 20.0 중량부 이상 사용할 경우 피부 부작용을 줄이기 어렵고, 제제의 안정성 또한 나쁘게 되어 제품화시키기 어렵다. 지질액정겔 역시 0.5 중량부 이하에서는 효과가 미미하며, 10.0 중량부 이상에서는 제제의 안정성이 나쁘게 되어 사용하기 어렵다. 또한 지질액정겔 제소시 위에서 언급한 범위를 벗어날 경우는 융점이 낮거나 높아 제제내에 안정화시키기 어려우므로 지질액정겔을 화장료 조성물에 적용하기 위해서는 상기 비율의 범위내에서 제조하는 것이 바람직하다.If the amount of alpha hydroxy acid is less than 0.5, the effect is insignificant, and if it is used more than 20.0 parts by weight, it is difficult to reduce the side effects of the skin, and the stability of the formulation is also bad, making it difficult to commercialize. Lipid liquid gel is also less effective at 0.5 parts by weight or less, and more than 10.0 parts by weight of the formulation is poor in stability is difficult to use. In addition, when the lipid liquid gel is out of the above-mentioned range, the melting point is low or high, so it is difficult to stabilize in the formulation. Therefore, in order to apply the lipid liquid gel to the cosmetic composition, it is preferable to prepare within the above ratio.

한편 본 발명에서 유중수형 유화물을 제조함에 있어서, 외상인 유상중에 시클로메치콘이 50.0 중량부 이하에서는 유중수형 유화물의 단점인 끈적임과 뻑뻑함 등이 있어 사용감이 좋지 못하다.On the other hand, in the production of water-in-oil emulsions, cyclomethicone is less than 50.0 parts by weight of the oil-in-water phase of the trauma, there is a bad feeling of stickiness and stiffness, which is a disadvantage of the water-in-oil type emulsions.

이하 본 발명을 실시예와 비교예 들을 통하여 상세히 설명한다.Hereinafter, the present invention will be described in detail through examples and comparative examples.

[실시예 1. 액정겔 베이스의 제조]Example 1 Preparation of Liquid Crystal Gel Base

다음의 표 1에 나타낸 원료 및 조성에 따라 이들을 혼합하고, 85 내지 90℃ 로 가열 용해 후 냉각시키고, 65 내지 70℃ 에서 호모믹서 500 내지 2000 rpm 으로 교반한 후, 실온까지 자연냉각시켜 액정겔 베이스를 제조하였다.According to the raw materials and compositions shown in Table 1 below, these were mixed, heated and dissolved at 85 to 90 ° C, cooled, and stirred at a homomixer at 500 to 2000 rpm at 65 to 70 ° C, and then cooled to room temperature to naturally cool the liquid crystal gel base. Was prepared.

[표 1]TABLE 1

Figure kpo00002
Figure kpo00002

주 1) 상품명 : Ceramide LS 3773 (Lab. Sero. 프랑스)Note 1) Product Name: Ceramide LS 3773 (Lab. Sero. France)

2) 상품명 : LanetteO (Henkel, 독일)2) Product Name: LanetteO (Henkel, Germany)

3) 상품명 : Emalex 515H (Nihon Emulsion, 일본)3) Product Name: Emalex 515H (Nihon Emulsion, Japan)

[실시예 2]Example 2

다음의 표 2에 나타낸 원료 및 조성에 따라 유상과 수상을 각각 65 내지 70℃로 가열 용해하고 호모믹서 4,000 내지 7,000 rpm으로 교반하면서 유상에 수상을 서서히 투입, 혼합하여 유중수형 유화물을 만든다. 이때 액정겔 베이스와 시클로메치콘은 유상과 수상을 혼합하기 직전 투입시키고, 첨가제인 향료는 수상과 유상을 완전히 혼합한 후 투입한다.According to the raw materials and the composition shown in Table 2 below, the oil phase and the water phase were heated and dissolved at 65 to 70 ° C., respectively, and the oil phase was gradually added and mixed while stirring at a homomixer at 4,000 to 7,000 rpm to form a water-in-oil emulsion. At this time, the liquid crystal gel base and the cyclomethicone are added just before mixing the oil phase and the water phase, and the flavoring agent as an additive is added after mixing the water phase and the oil phase completely.

[표 2]TABLE 2

Figure kpo00003
Figure kpo00003

주 1 ) 상품명 : KF-6017(Shin Etsu, 일본)Note 1) Product Name: KF-6017 (Shin Etsu, Japan)

2 ) 상품명 : Silicone 344 (Dow Corning, 미국)2) Product Name: Silicone 344 (Dow Corning, USA)

[비교예 1]Comparative Example 1

다음의 표 3에 나타낸 원료 및 조성에 따라 통상적인 화장품용 기제인 수중유형 유화물에 알파히드록시산을 배합하여 제조하였다. 이의 제조방법으로는 수상과 유상을 각각 75 내지 80℃로 가열 용해시키고 호모믹서를 이용하여 4,000 내지 6,000rpm으로 혼합시켜 실온까지 냉각하여 제조한다. 이때 향료는 수상과 유상을 혼합후 냉각과정에서 투입 혼합한다.According to the raw materials and compositions shown in Table 3 below, alpha hydroxy acids were prepared by blending an oil-in-water emulsion, which is a conventional cosmetic base. In the preparation method thereof, the aqueous phase and the oil phase are each dissolved by heating at 75 to 80 ° C., mixed at 4,000 to 6,000 rpm using a homomixer, and cooled to room temperature. At this time, the flavor is mixed in the cooling process after mixing the water and oil phase.

[표 3]TABLE 3

Figure kpo00004
Figure kpo00004

주 1) 상품명 : Amphisol K (Givaudan, 스위스)Note 1) Trade name: Amphisol K (Givaudan, Switzerland)

[비교예 2]Comparative Example 2

다음의 표 4에 나타낸 원료 및 조성에 따라 일반적인 화장품용 유중수형 유화물기제에 알파히드록시산을 배합하여 제조하였다.According to the raw materials and compositions shown in Table 4 below, alpha hydroxy acid was added to a general water-in-oil emulsion for cosmetics.

이의 제조방법으로서는 실시예 2의 경우와 같다.As a manufacturing method thereof, it is the same as in the case of Example 2.

[표 4]TABLE 4

Figure kpo00005
Figure kpo00005

주 1 ) 상품명 : Drakeol-7(Penreco, 미국)Note 1) Product Name: Drakeol-7 (Penreco, USA)

2 ) 상품명 : Arlacel 989 (ICI, 미국)2) Product Name: Arlacel 989 (ICI, USA)

피부 1차 자극성 시험(첩포시험)Skin primary irritation test (patch test)

상시 실시예 및 비교예에 따라 제조된 제품들의 피부자극성을 알아보기 위하여 건강한 성인 남·여 50명을 대상으로 등부위에 각 시료의 일정량(약 0.2g)을 첩포한 후 핀 챔버를 제거하고 4시간 경과한 다음 육안으로 피부상태 변화를 판독하였으며, 그 결과를 표 5에 나타내었다.In order to examine the skin irritation of the products prepared according to the Examples and Comparative Examples, a certain amount (approximately 0.2 g) of each sample was applied to the back area of 50 healthy men and women and the pin chamber was removed for 4 hours. After the change of skin condition was visually read, the results are shown in Table 5.

[표 5]TABLE 5

Figure kpo00006
Figure kpo00006

* 판정기준 - : 홍반이나 특이한 현상없슴* Criteria-: No erythema or unusual phenomenon

+- : 주위보다 약간 붉어짐+-: Slightly reddish

+ : 주위보다 현저히 붉어짐+: Significantly redder than the surroundings

++ : 주위보다 심하게 붉어지고 부풀음++: Severe reddening and swelling around

** 자극도

Figure kpo00007
** Stimulus
Figure kpo00007

상기 표 5의 피부 1차 자극성 시험결과에서 알 수 있는 바와 같이, 알파히드록시산을 액정겔베이스에 포함시킨 실시예 2가 액정겔베이스를 사용하지 않은 비교예 2보다 낮은 자극도를 나타내었다.As can be seen from the skin primary irritation test results of Table 5, Example 2 containing alpha hydroxy acid in the liquid crystal gel base exhibited a lower irritation degree than Comparative Example 2 without using the liquid crystal gel base.

[경피흡수 측정시험][Percutaneous absorption measurement test]

알파히드록시산 또는 그의 염에 대한 경피흡수 촉진효과를 측정하기 위해 헤어리스마우스의 피부를 이용해 in vitro 피부투과시험을 행하였다. 직경 7.5mm의 피부표면에 시료를 48㎕ 주입하고 경피흡수기기(Hanson 社 Microette)를 이용하여 각 경과시간 동안에 투과된 양을 고속액체크로마토그래피로 정량하여 표 6에 투과율(%)로 나타내었다.In vitro skin permeation tests were performed using the skin of hairless mice to determine the effect of promoting transdermal absorption on alpha hydroxy acids or salts thereof. 48 μl of the sample was injected into the skin surface having a diameter of 7.5 mm, and the amount permeated during each elapsed time using a transdermal absorber (Micron, Hanson) was quantified by high performance liquid chromatography, and the transmittance (%) is shown in Table 6.

[표 6]TABLE 6

Figure kpo00008
Figure kpo00008

표 6에 나타난 바와 같이, 액정겔 베이스가 첨가된 실시예 2가 비교예 1 및 비교예 2에 비해 일정량이 계속 투과됨을 알 수 있었으며 이는 곧 알파히드록시산이 일시적으로 많은 양이 침투하지 않으므로 피부부작용을 유발하지 않으면서 효과는 지속적인 것을 의미한다.As shown in Table 6, it can be seen that Example 2 to which the liquid crystal gel base is added is continuously penetrated compared to Comparative Example 1 and Comparative Example 2, which means that the alpha hydroxy acid does not temporarily penetrate a large amount of skin side effects. The effect is meant to be lasting without causing it.

[사용감 평가시험][Evaluation Test]

상기 실시예 및 비교예들의 사용감을 알아보고자 20~50세의 여성을 대상으로 사용감에 대한 품질 평가설문을 실시하였다. 사용감에 대한 품질 평가항목을 각각 5점 척도법을 이용하여 설문 조사한 결과는 다음 표 7에 나타낸 바와 같다. 실시예 2는 유상중에 시클로메치콘이 50.0 중량부 이상 함유되어 있어, 비교예 2와 같은 일반 유중수형 유화물이 갖는 사용감 즉, 끈적이고 흡수가 느리며, 무겁게 발리는 단점을 개선했으며, 일반 수중유형 유화물인 비교예 1과 거의 유사한 사용감을 나타내었다.To evaluate the feeling of use of the examples and comparative examples, a quality evaluation questionnaire was conducted for women aged 20 to 50 years. The results of the questionnaire survey using the five-point scale method for the quality evaluation items for feeling are shown in Table 7 below. Example 2 contained more than 50.0 parts by weight of cyclomethicone in the oil phase, improving the feeling of use of the general water-in-oil emulsion like Comparative Example 2, that is, sticky, slow absorption, heavy coating, and general oil-in-water emulsion The feeling was almost similar to that of Comparative Example 1.

[표 7]TABLE 7

Figure kpo00009
Figure kpo00009

Claims (4)

알파히드록시산 또는 그의 염중 1종 또는 2종 이상을 0.5~20.0 중량부와 액정겔 베이스를 0.5~10.0 중량부 배합한 것을 특징으로 하는 유중수 타입의 화장료 조성물.A water-in-oil type cosmetic composition comprising 0.5 to 20.0 parts by weight of an alpha hydroxy acid or salts thereof or 0.5 to 10.0 parts by weight of a liquid crystal gel base. 제 1항에 있어서, 유중수 타입이라함은 외상인 유상중에 시클로메치콘이 50.0 중량부 이상 함유된 것으로서, 시클로메치콘은 다음과 같은 기본구조식을 갖는 것임을 특징으로 하는 화장료 조성물.The cosmetic composition according to claim 1, wherein the water-in-oil type contains 50.0 parts by weight or more of cyclomethicone in the oil phase, which is an external wound, and the cyclomethicone has a basic structural formula as follows.
Figure kpo00010
Figure kpo00010
제 1항에 있어서, 액정겔 베이스라함은 세라마이드 9.0~12.0 중량부, 콜레스테롤 2.0~4.0 중량부, 세토스테아릴알코올 1.0~3.0 중량부, 피이지 -15 올레이트 3.0~7.0 중량부, 프로필렌글리콜 74.0~85.0 중량부로 구성된 것을 특징으로 하는 화장료 조성물.According to claim 1, wherein the liquid crystal gel base is Ceramide 9.0-12.0 parts by weight, Cholesterol 2.0-4.0 parts by weight, 1.0 to 3.0 parts by weight of cetostearyl alcohol, 3.0 to 7.0 parts by weight of sebum -15 oleate, propylene glycol 74.0 Cosmetic composition, characterized in that consisting of ~ 85.0 parts by weight. 제 1항에 있어서, 알파히드록시산 또는 그의 염이라함은 알파탄소 위치에 수산기를 갖는 유기산, 즉, 글리콜산, 젖산, 히드록시부틴산, 말산 및 이들을 알카리로 중화시킨 글리콜산나트륨, 글리콜산칼륨, 젖산나트륨, 젖산칼륨, 히드록시부틴산나트륨, 히드록시부틴산칼륨, 말산나트륨, 말산칼륨 중에서 1종을 함유함을 특징으로 하는 화장료 조성물.The method according to claim 1, wherein alpha hydroxy acid or a salt thereof is an organic acid having a hydroxyl group at an alpha carbon position, that is, glycolic acid, lactic acid, hydroxybutyric acid, malic acid, and sodium glycolate and glycolic acid which are neutralized with alkali. A cosmetic composition comprising one of potassium, sodium lactate, potassium lactate, sodium hydroxybutyrate, potassium hydroxybutyrate, sodium malate and potassium malate.
KR1019970031102A 1997-07-04 1997-07-04 Low irritating cosmetic compositions containing alphahydroxy acids KR100245390B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019970031102A KR100245390B1 (en) 1997-07-04 1997-07-04 Low irritating cosmetic compositions containing alphahydroxy acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019970031102A KR100245390B1 (en) 1997-07-04 1997-07-04 Low irritating cosmetic compositions containing alphahydroxy acids

Publications (2)

Publication Number Publication Date
KR19990008898A KR19990008898A (en) 1999-02-05
KR100245390B1 true KR100245390B1 (en) 2000-03-02

Family

ID=19513433

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970031102A KR100245390B1 (en) 1997-07-04 1997-07-04 Low irritating cosmetic compositions containing alphahydroxy acids

Country Status (1)

Country Link
KR (1) KR100245390B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100431270B1 (en) * 2001-03-02 2004-05-12 주식회사 엘지생활건강 Anti-wrinkle solid cosmetic composition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960033439A (en) * 1995-03-21 1996-10-22 성재갑 Liquid crystal gel stabilized vitamin A palmitate and cosmetic composition containing the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960033439A (en) * 1995-03-21 1996-10-22 성재갑 Liquid crystal gel stabilized vitamin A palmitate and cosmetic composition containing the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100431270B1 (en) * 2001-03-02 2004-05-12 주식회사 엘지생활건강 Anti-wrinkle solid cosmetic composition

Also Published As

Publication number Publication date
KR19990008898A (en) 1999-02-05

Similar Documents

Publication Publication Date Title
JP3112436B2 (en) In particular, the use of honey as a keratolytic agent to improve the brightness of the skin facial and treat wrinkles
CA2132369C (en) Use for the treatment of mixed skins, of an effective quantity of active substances
HUT71728A (en) Slimming composition for topical treatment, containing two types of liposomes, and use thereof
KR100859677B1 (en) Pharmaceutical compositions for reducing the appearance of dark circles under the eyes
JP3383496B2 (en) Method for producing liquid crystal emulsion and liquid crystal emulsion composition obtained by the method
JPH0657651B2 (en) Cosmetic composition
CA2365660A1 (en) Treatment for skin
KR100588743B1 (en) Emulsifying cosmetic composition containing a highly moisturizing liquid crystal
JPH08283303A (en) Emulsifier comprising higher fatty acid dextrin, emulsion composition containing the same, and cosmetic
WO1998013436A1 (en) Humectant composition, base containing the same, and cosmetic material or external preparation containing said humectant composition
JPH08310941A (en) Oil-in-water type emulsified cosmetic for sunscreen
KR100245390B1 (en) Low irritating cosmetic compositions containing alphahydroxy acids
JPH022850B2 (en)
JPH08183726A (en) Skin preparation for external use
JPS61204109A (en) Emulsion-type composition for external use
JP2001206817A (en) Oil-in-polyhydric alcohol type thermal substrate
JPS6231975B2 (en)
JP7620104B2 (en) Method for producing a cosmetic composition comprising a sucrose ester and a solvent
JPS6256411A (en) Beautifying agent
JP2000072618A (en) Emulsifying agent for preparation for external use for skin
JPH0349886B2 (en)
JP2001278768A (en) Skin care preparation
JP2014141479A (en) Method for improving percutaneous absorption of active ingredient, and cosmetic
JP2000191499A (en) Cosmetic for moisturiztng skin
JPH07285846A (en) Promoter for production of collagen and skin cosmetic containing the same blended therein

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19970704

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19971029

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19970704

Comment text: Patent Application

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19990527

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19990830

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19991129

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19991130

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20021029

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20031022

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20041022

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20051025

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20060801

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20070906

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20080910

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20080910

Start annual number: 10

End annual number: 10

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee